Pharma giants Sanofi and GSK have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine, the firms announced Wednesday.
/https://cdn.mihaaru.com/photos/2020/07/29/281120_3_ba0717883bc15b3d7317ae38db3d724475809933_large.jpg)
A lab technician in Personal Protective Equipment (PPE) looks at a reagent bottle before performing vaccine tests at a French pharmaceutical company Sanofi's laboratory in Val de Reuil on July 10, 2020. (Photo by JOEL SAGET / AFP)
2020-07-29 11:30:00
Pharma giants Sanofi and GSK have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine, the firms announced Wednesday.
The agreement covers a vaccine candidate developed by France's Sanofi in partnership with the UK's GSK and is subject to a "final contract".
Copyright © 2025 The Edition
/https://cdn.mihaaru.com/photos/2025/03/03/412239_3_0d44335ad3c46bcc013565bc8f2b060cc771eb05_large.jpg)
/https://s3.mihaaru.com/photos/2024/11/18/405822_3_42991b287152e728fb9dc1a34b047616b3c170b2_large.jpg)
/https://cdn.mihaaru.com/photos/2025/02/22/411540_3_4a48676775adcce55fa65b35db06d54c556c2d45_large.jpg)
/https://cdn.mihaaru.com/photos/2025/01/20/409609_3_8619638b962d13f7368c9bfe329a353eeeb47616_large.jpg)